Preventing acute confusion after cardiovascular procedures through prevention

An analysis of approximately 1,604 studies from over three decades proves that delirium is a clinically highly relevant but ...
Nasdaq

CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution

CeriBell Inc. CBLL recently announced that the FDA has given 510(k) clearance for its latest delirium monitoring solution, making it the one and only FDA-cleared solution for continuous tracking of ...
Seeking Alpha

Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution

SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious ...